Company intelligence / Profile preview

Oncologica

Saffron Walden, England, United Kingdom

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Oncologica is a leading precision oncology laboratory delivering rapid, comprehensive genomic profiling (Oncofocus test) to identify actionable mutations and guide clinicians to optimal targeted therapies, covering 505 genes linked to 700 anti-cancer treatments. They also provide urine liquid biopsy for early prostate cancer detection. No publicly reported interventional clinical results, as this is a diagnostics/services company

Therapeutic areas: Oncology
Modalities: Diagnostic technologiesGenomic profilingAI-driven genetic testingLaboratory services (no evidence of therapeutic product development as a biotech—focus is service-oriented)
Industry: Molecular Diagnostics

Partnerships

Ellab (environmental monitoring technology partner)major private health insurers (Oncofocus test coverage)

Beyond the preview

Go deeper on Oncologica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncologica.

Explore the full profile